Most Recent Articles by Britt Gambino
The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.
The new rapid rule-out for MI protocol had sensitivity and negativity predictive values of 100% and a specificity of 86%.
The FDA aims to support the development of novel inhaled nicotine replacement therapies to combat the public health crisis of tobacco use in the United States.
Medicare beneficiaries spent more out of pocket for generic medications used to treat cardiovascular disease than patients using standalone prescription drug plans.
Siblings of patients with rheumatoid arthritis appear to have an increased risk for acute coronary syndrome, which suggests there is a shared susceptibility between the 2 conditions.
More Articles by Britt Gambino
The Cardiology Advisor Articles
- AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease
- American Heart Association Urges Screen Time Limits for Youth
- Patient Connectivity Benefits Familial Chylomicronemia Syndrome
- Genetic Screening in Preventive Care: Advances and Challenges
- Exercise Benefits for Myocardial Infarction Not Reduced by Traffic Pollutants
- Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease
- Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension
- Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
- The Challenge of Compassion in Modern Healthcare Settings
- Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Relationship Between HbA1c and Coronary Artery Disease
- E-Cigarette Vapor Condensate Toxic to Alveolar Macrophages
- Death Risk Not Increased in T2DM When Risk Factors Within Target
- AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy